Event ID- 3B17DF57C67A4823BF56A57E1A590294 Autofiller widget ID- B2E9CC70EC1546BFB53AB1AE52F59949 Activator Widget ID- FF16DBE1E83F4AAD98F309FF06682196 Confirmation Widget ID-22989446DE4E477DAC8B5245CE2AFA1F Amplifier ID- 91C209426D3B49B58C45CC6C7827D349


Associate Sponsor

About Abzena 

Abzena is the new name for the PolyTherics group, and is focused on providing proprietary technologies and value-added services to enable the development of better biopharmaceuticals.

Abzena comprises two wholly owned subsidiary businesses – PolyTherics and Antitope – which have established a broad suite of complementary technologies that are designed to improve the chances of successful development of antibodies and proteins with enhanced therapeutic benefits.

PolyTherics specializes in proprietary site-specific conjugation technologies for antibody drug conjugate development and solutions for optimisation of the therapeutic properties of biopharmaceuticals.

Antitope provides immunogenicity assessment, protein engineering to create humanized antibodies and deimmunised therapeutic proteins and cell line development for manufacture.

The group has built a global customer base over the past decade, including the top 10 pharma, large and small biotech, and academic groups.
Company Description